Brief: Eton Pharmaceuticals Q3 Net Income USD -579 Thousand
09/11/2023 21:01
Nov 09 (Reuters) - Eton Pharmaceuticals Q3 gross profit USD 4.403 million. * Q3 operating expenses USD 4.951 million * Q3 pretax profit USD -579 thousand * Q3 income from operations USD -548 thousand * Q3 basic EPS USD -0.02 * Q3 EPS USD -0.02
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer